Opzelua

Novartis JAKs in rival to Incyte's topical eczema drug after seeing clinical data
Fierce Biotech
Wed, 02/2/22 - 10:59 am
Novartis
Incyte
JAK inhibitors
Opzelua
eczema
atopic dermatitis